Previous Article | Next Article ![]()
Infect. Immun., 05 1995, 1887-1892, Vol 63, No. 5
F De Bernardis, A Cassone, J Sturtevant and R Calderone
Several strains of Candida albicans were compared for their ability to
cause vaginal infection in a rat model, and their vaginopathic potentials
were correlated with the expression of two aspartyl proteinases genes (SAP1
and SAP2) and adherence in vivo to the vaginal epithelium. Dot blot
reactions and Northern blot analysis with RNA extracted from the vaginal
fluid of rats infected with the highly vaginopathic strains H12 and 10261
demonstrated the expression of both SAP1 and SAP2 during the first week of
infection. In contrast, neither gene was expressed during infection by a
nonvaginopathic strain (N), even though the organism could be recovered
during the first 24 h postinfection. A moderately vaginopathic strain (P)
also expressed both genes, but the level of SAP1 mRNA appeared to decrease
prior to that of SAP2. Neither gene was expressed, even by the highly
vaginopathic strains, after the first week of infection, concomitant with a
decrease in the number of organisms recovered from the vaginas. Analysis of
in vivo adherence showed that the nonvaginopathic strain (N) adhered to
vaginal epithelial cells less readily than the highly vaginopathic strain
(H12) and moderately vaginopathic strain (P). Thus, in addition to its
inability to express SAP1 and SAP2 in vivo, the nonvaginopathic strain does
not colonize host cells to the same extent as the other strains tested. Our
results demonstrate the early in vivo expression of two aspartyl proteinase
gene during candidal vaginitis and suggest its association with the
establishment of a vaginal infection.
Copyright © 1995, American Society for Microbiology
Expression of Candida albicans SAP1 and SAP2 in experimental vaginitis
Laboratory of Bacteriology and Medical Mycology, Istituto Superiore di Sanita, Rome, Italy.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|